HK Stock MarketDetailed Quotes
06660 AIM VACCINE
- 7.340
- +0.450+6.53%
Market Closed Nov 26 16:08 CST
8.89BMarket Cap-6815P/E (TTM)
8.270High6.810Low16.01MVolume6.810Open6.890Pre Close121.12MTurnover3.25%Turnover RatioLossP/E (Static)1.21BShares15.48052wk High2.32P/B3.61BFloat Cap3.95052wk Low--Dividend TTM492.17MShs Float100.000Historical High--Dividend LFY21.19%Amplitude3.950Historical Low7.565Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
AIM VACCINE Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -0.61%537.18M | -6.06%1.19B | --540.47M | -19.49%1.26B | -4.14%1.57B | 26.53%672.56M | 72.12%1.64B | --531.56M | -14.36%951.65M | --1.11B |
| Operating income | -0.61%537.18M | -6.06%1.19B | 540.47M | -19.49%1.26B | -4.14%1.57B | 26.53%672.56M | 72.12%1.64B | 531.56M | -14.36%951.65M | 1.11B |
| Cost of sales | -38.09%-148.89M | -21.17%-286.45M | ---107.82M | 14.17%-236.41M | 2.98%-275.43M | -16.74%-124.08M | -29.74%-283.88M | ---106.29M | 10.69%-218.8M | ---244.98M |
| Operating expenses | -38.09%-148.89M | -21.17%-286.45M | -107.82M | 14.17%-236.41M | 2.98%-275.43M | -16.74%-124.08M | -29.74%-283.88M | -106.29M | 10.69%-218.8M | -244.98M |
| Gross profit | -10.25%388.29M | -12.32%901.02M | 432.65M | -20.63%1.03B | -4.39%1.29B | 28.97%548.48M | 84.77%1.35B | 425.27M | -15.39%732.85M | 866.19M |
| Selling expenses | -3.26%-232.24M | -0.17%-494M | ---224.9M | -7.18%-493.17M | 13.71%-460.11M | -29.33%-228.83M | -61.59%-533.25M | ---176.94M | 30.48%-330.01M | ---474.71M |
| Administrative expenses | -7.35%-124.16M | 43.59%-254.29M | ---115.66M | 61.41%-450.76M | -487.82%-1.17B | -1,049.55%-1.03B | -26.41%-198.7M | ---89.23M | 16.48%-157.18M | ---188.19M |
| Research and development expenses | 57.32%-170.11M | -27.20%-636.4M | ---398.53M | -62.78%-500.31M | -94.82%-307.35M | -202.11%-139.61M | -59.54%-157.76M | ---46.21M | -76.10%-98.89M | ---56.15M |
| Impairment and provision | -5.10%-3.86M | -6,473.38%-1.79B | ---3.67M | -241.00%-27.22M | -866.22%-7.98M | -64.36%-2.5M | -139.28%-826K | ---1.52M | 117.82%2.1M | ---11.8M |
| -Impairment of intangible assets | ---- | ---1.51B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of property, machinery and equipment | ---- | ---61.09M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---211.44M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | -5.10%-3.86M | 84.64%-4.18M | ---3.67M | -241.00%-27.22M | -866.22%-7.98M | -64.36%-2.5M | -139.28%-826K | ---1.52M | 117.82%2.1M | ---11.8M |
| Special items of operating profit | -34.15%12.77M | 29.69%45.8M | --19.39M | -33.02%35.32M | 38.49%52.73M | 126.16%25.09M | 103.92%38.07M | --11.09M | 50.19%18.67M | --12.43M |
| Operating profit | 55.52%-129.31M | -445.16%-2.23B | -290.72M | 31.46%-408.47M | -218.81%-596M | -772.10%-823.11M | 199.40%501.63M | 122.47M | 13.38%167.54M | 147.77M |
| Financing cost | -56.60%-30M | -70.60%-43.83M | ---19.16M | -140.05%-25.69M | 32.01%-10.7M | 46.05%-5.41M | -46.01%-15.74M | ---10.04M | -47.28%-10.78M | ---7.32M |
| Earning before tax | 48.59%-159.31M | -422.99%-2.27B | -309.88M | 28.44%-434.17M | -224.87%-606.7M | -836.91%-828.53M | 209.95%485.89M | 112.43M | 11.61%156.76M | 140.45M |
| Tax | -73.22%14.05M | 57.42%320.4M | --52.45M | 394.25%203.54M | 19.07%-69.17M | -45.23%-34.77M | -131.34%-85.47M | ---23.94M | 5.34%-36.95M | ---39.03M |
| After-tax profit from continuing operations | 43.57%-145.26M | -745.61%-1.95B | -257.43M | 65.88%-230.63M | -268.79%-675.87M | -1,075.54%-863.29M | 234.20%400.41M | 88.49M | 18.14%119.81M | 101.42M |
| Earning after tax | 43.57%-145.26M | -745.61%-1.95B | -257.43M | 65.88%-230.63M | -268.79%-675.87M | -1,075.54%-863.29M | 234.20%400.41M | 88.49M | 18.14%119.81M | 101.42M |
| Minority profit | 14.91%-6.01M | -829.72%-649.24M | ---7.06M | 426.42%88.97M | -20.00%16.9M | -130.54%-1.44M | 777.37%21.13M | --4.73M | -97.34%2.41M | --90.37M |
| Profit attributable to shareholders | 44.38%-139.25M | -307.07%-1.3B | -250.37M | 53.87%-319.6M | -282.65%-692.77M | -1,128.88%-861.85M | 223.06%379.29M | 83.77M | 962.11%117.41M | 11.05M |
| Basic earnings per share | 47.62%-0.11 | -296.30%-1.07 | -0.21 | 55.00%-0.27 | -253.85%-0.6 | -955.56%-0.77 | 178.57%0.39 | 0.09 | 1,300.00%0.14 | 0.01 |
| Diluted earnings per share | 47.62%-0.11 | -296.30%-1.07 | -0.21 | 55.00%-0.27 | -253.85%-0.6 | -955.56%-0.77 | 178.57%0.39 | 0.09 | 1,300.00%0.14 | 0.01 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data